Drug-Nutrient Interactions in the Elderly

Pages 1-5: Overview of Geriatric Physiology and Aging Concepts

  • Objective: Manage successful aging by minimizing deleterious effects, preventing disabilities, and increasing HRQOL (Health-Related Quality of Life).
  • Frailty: Defined as a loss of physiologic reserve (multisystemimpairmentmultisystem impairment) that increases susceptibility to disability from minor stressors.
  • Dimensions of Aging:
    • Physical: Issues such as unintentional weight loss and balance problems.
    • Psychological: Memory issues and coping difficulties.
    • Social: Living alone or lack of support systems.
  • Statistic: At least 80%80\% of the elderly population has at least one chronic condition.

Pages 6-10: Medication Use and Supplement Proliferation

  • Institutionalized Drug Use: Average of 55 agents per patient per month; 9%9\% take 1010 or more drugs daily.
  • Over-the-Counter (OTC) Use: Common for arthritis and constipation, including NSAIDs, insulin, and laxatives.
  • Dietary Supplements: Rising use of products such as Vitamin E, Gingko, Ginseng, Garlic, and St. John’s wort.
  • Vitamin E Risk: High doses may modulate insulin but increase bleeding risk with warfarin and potentially worsen infections.

Pages 11-14: Medication Appropriateness and Adverse Events

  • Beers’ Criteria: A clinical list developed by Beers and colleagues to identify medications best avoided in the elderly.
  • Inappropriate Prescribing: Approximately 25%25\% of community-dwelling elderly receive potentially inappropriate medications.
  • Hospitalization Origins: Adverse drug events (ADEs) leading to hospitalization are most frequent for Cardiovascular (33.3%33.3\%) and CNS (27.8%27.8\%) therapies.

Pages 15-20: Physiologic and Pharmacokinetic (PK) Transformations

  • Physiologic Shifts: Decreased lean body mass, total body water, and albumin; increased body fat and gastric pHpH.
  • Pharmacokinetic Changes:
    • Absorption: Increased bioavailability for drugs with a high first-pass effect (e.g., fentanyl, propranolol, verapamil).
    • Distribution: Lower albumin increases the free (active) fraction of acidic drugs. Increased body fat extends the half-life of lipid-soluble medications.
    • Excretion: Declining renal mass and blood flow reduce creatinine clearance (CrClCrCl), usually requiring prospective dose adjustments.

Pages 21-26: Malnutrition Screening and Weight Loss Etiology

  • Assessment Tools: Mini Nutritional Assessment (MNA) and S.C.A.L.E.S. (SadnessSadness, Cholesterol<4.14mmol/LCholesterol \lt 4.14\,\text{mmol/L}, Albumin<40g/LAlbumin \lt 40\,\text{g/L}, LossofweightLoss\,of\,weight, EatingproblemsEating\,problems, ShoppingproblemsShopping\,problems).
  • Identify Causes: The "MEALS ON WHEELS" acronym is used, starting with Medication as a primary treatable cause for weight loss.
  • Drug-Induced Mechanisms: Anorexia, malabsorption, or hypermetabolism caused by agents such as Digoxin, Metformin, and Laxatives.

Pages 27-32: Geriatric Nutritional Requirements

  • Energy Requirements: Averaging 25kcal/kg25\,\text{kcal/kg} daily.
  • Protein Requirements: Maintain at 1g/kg1\,\text{g/kg} daily.
  • Fluid Requirements: Significant risk of dehydration; requires 30mL/kg30\,\text{mL/kg} daily.
  • Micronutrient Shifts: Higher requirements for Calcium, Vitamin D, B6B_6, and B12B_{12}; lower requirements for Chromium and Vitamin A.

Pages 33-35: Mechanisms of Drug-Nutrient Interactions

  • Physical Barriers: Food can alter gastric emptying rates or react physicochemically (e.g., chelation).
  • Fatty Meals: Decrease motility and gastric emptying, which affects drugs requiring rapid absorption or those unstable in acidic environments.
  • Herbal Interactions: St. John’s wort interacts with theophylline, cyclosporin, and digoxin. Ginkgo interacts with aspirin and warfarin.

Pages 36-47: Specific Drug-Nutrient Interactions by Class

  • Anticoagulants (Warfarin): Interacts with Vitamin E, Garlic, and Ginseng. Patients must maintain a consistent intake of Vitamin K foods.
  • Antiepileptics (Phenytoin): Interacts with tube feedings; folic acid can decrease phenytoin concentrations.
  • Antidepressants (MAOIs): Nonselective MAOIs interact with Tyramine (found in aged cheese, wine, and cured meats), potentially causing fatal hypertensive crises.
  • Antimicrobials (Tetracyclines/Fluoroquinolones): Chelate with polyvalent cations (Calcium, Magnesium, Iron, Aluminum) in dairy or antacids.
  • Endocrine (Metformin): May cause Vitamin B12B_{12} malabsorption; calcium administration may mitigate this.
  • Osteoporosis (Bisphosphonates): Oral bioavailability is <1%\lt 1\%; coffee or juice can reduce this by 60%60\%. Must be taken in a fasting state.
  • Gastrointestinal (PPIs): Acid-labile; should be administered with acidic juices (apple/orange) and avoided with milk.
  • Bile Acid Sequestrants/Laxatives: Cholestyramine and mineral oil can deplete fat-soluble vitamins (AA, DD, EE, KK).

Pages 48-54: Parkinson Agents and Weight-Influencing Meds

  • Levodopa: Competes with large neutral amino acids from dietary protein for transport; interaction is significant in continuous enteral nutrition.
  • Weight Gain: Psychoactive drugs, Tricyclic Antidepressants (TCAs), and insulin often cause weight gain and carbohydrate cravings.
  • Diuretics: Lead to fluid/electrolyte imbalances, specifically hyponatremia and hypokalemia.
  • Corticosteroids: Cause sodium retention, potassium wasting, and calcium depletion, increasing osteoporosis risk.

Pages 55-61: Clinical Recommendations and Assessment

  • Medication Appropriateness Index (MAI): Use Hanlon’s instrument for routine drug therapy evaluation.
  • Comprehensive Geriatric Assessment: A team approach covering functional, cognitive, social, and nutritional domains.
  • Education: Targeted programs and workbooks (e.g., Byeth and colleagues' warfarin workbook) effectively reduce adverse drug events and bleeding complications.